CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Patient Immunotherapy Summit: Breast Cancer Brief

    While one in eight women in the U.S. will develop breast cancer in their lifetime, the good…
    January 9, 2024| Max Mallet
  • Patient Immunotherapy Summit: I’m the Answer to Cancer™ Jeff’s Patient Story

    Since immunotherapy has become a more mainstream form of cancer treatment, more people are choosing to use…
    January 8, 2024| Max Mallet
  • Patient Immunotherapy Summit: Ovarian Cancer Brief

    It is important for the public to be aware of the scope of ovarian cancer, as over…
    January 8, 2024| Max Mallet
  • Patient Immunotherapy Summit: Pancreatic Cancer Brief

    Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading…
    January 8, 2024| Max Mallet
  • Immunotherapy 101: What is Immunotherapy and How Does it Work?

    Jedd Wolchok, MD, PhD, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill…
    January 8, 2024| Max Mallet
  • CRI’s 7th Annual Patient Immunotherapy Summit – December 2023 Full Cut 

    The Cancer Research Institute’s 7th Annual Patient Immunotherapy Summit hosts a plethora of impactful information that cancer…
    January 8, 2024| Max Mallet
  • cancer types

    Exploring the Different Types of Cancer and Treatment Options

    Cancer is a formidable adversary, but our understanding of this disease has come a long way. Cancer…
    December 12, 2023| CRI Staff
  • Hand holding up an X-ray of a lung

    Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow

    CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine…
    December 6, 2023| Ajit Muley, PhD
  • CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide 

    A Large Cancer Presence on a Global Scale  The Cancer Research Institute (CRI) has a singular focus:…
    November 17, 2023| Max Mallet
Previous Page
1 … 3 4 5 6 7 … 12
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute